FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy
The US Food and Drug Administration (FDA) has approved a supplemental new drug application for vutrisiran for the treatment of...
The US Food and Drug Administration (FDA) has approved a supplemental new drug application for vutrisiran for the treatment of...